![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Production & Manufacturing
Catalent To Develop Softgel Capsules For JOT’s Leading Orphan Disease Candidates
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. ...
News
Alexion Says FDA Grants Orphan Drug Designation To ALXN1210
Alexion Pharmaceuticals Inc announced that the U.S. FDA has granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting anti-C5 antibody that inhibits...
Drug Research
Takeda and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease
Takeda Pharmaceutical Company Limited and PvP Biologics, Inc announced a global agreement for the development of KumaMax, a novel enzyme designed to break down...
Articles
Applying New Approaches to Containment and Delivery of Diabetes Medications
Type 2 diabetes awareness is rising in the United States. Public and private health leaders are now offering screenings and patient education sites that...
Press Releases
Global pharma players trust in Swisslog to strengthen intralogistics
Swisslog, a leading automation expert for robot-based and data driven intralogistic solutions, has completed the latest expansion of the high-bay warehouse for healthcare manufacturers....
White Papers
Six Trends in Pharma Marketing
Embracing Digital Transformation in the Pharma and Healthcare Sectors A Marketer’s Guide The New Reality:Nearly everything healthcare and pharma marketers did...
Clinical Trials
Renova Therapeutics selects Worldwide Clinical Trials as its CRO for RT-100 AC6 gene transfer
Renova  Therapeutics, a biotechnology company developing gene therapy treatments for congestive heart failure and type 2 diabetes. Announced that it has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read